What are you looking for?
Category
Environmental allergy and climate change Aerobiology and pollution T2 diseases Food allergy Epidemiology adolescent Immune deficiencies and autoimmunity OMIC technologies in allergy research Uncategorised Infections transitional Allergen immunotherapy Insect venom hypersensitivities mHealth Allergy diagnosis Microbiome SAC 2026 Allied health and primary care Occupational allergy Rhinitis Anaphylaxis Ocular allergy Exposome Asthma Pediatrics PRACTALL Basic immunology Prevention Hypersensitivity Biologicals Systems medicine angioedema Biomarkers One Health allergen immunotherapy (AIT) Immunomodulation and nutrition immunopharmacology Dermatology AllergoOncology Cost-effectiveness Drug allergy artificial intelligence (AI) ENT Allergy asthma and a sport food allergy and anaphylaxis
Keywords
Angioedema GRADE Prevention antibiotic atopy ants registry young adult inflammatory diseases severity score mechanisms Consensus omalizumab feeding exacerbations eczema arthropods nasal endoscopy allergen extracts innate lymphoid cells animal models white paper evidence-based allegen immunotherapy (AIT) severe asthma Rhinoconjunctivitis sensitization insects scoring system regulation therapeutic targets asthma; atopic dermatitis Allergic rhinitis (AR) Food Alergy hives AllergyMonitor® allergic disorders teenager oral food challenge saliva allergy clinical algorithm skin tests antivirals clinical immunology Rhinitis Food allergy itch MASK‐air® allergic diseases transition basophil activation test (BAT) venom allergy clinical guidance allergooncology heath care utilization tolerance induction allergy epidemiology Guidelines mast cell Chronic rhinosinusitis Asthma asthma control Drug allergy diagnosis biodiversity hyperinflammation cancer respiratory Basophil allergy hypersensititvy IgE Urticaria Chronic rhinosinusitis with nasal polyposis (CRSwNP) telemedicine asthma exacerbations eosinophil climate change intravenous immunoglobulin oncoimmunology Vaccination component-resolved diagnosis (CRD) allergy management C1 inhibitor wheal dupilumab Allergy house dust mites clinical outcomes One Health multisystem inflammatory syndrome in children (MIS-C) tolerance viral infection Mast cells global atlas DELPHI immunomodulation and nutrition Mepolizumab Artificial intelligence Lung function tests subcutaneous apps SARS-CoV-2 allergology Drug Hypersensitivity; contact dermatitis disease control pediatrics reslizumab environment allergen immunotherapy ARIA Allergy diagnosis competences ENDA Dermatology hereditary angioedema constipation cell metabolism exposome allergic conjunctivitis consensus document digital healthy Allergy treatment subspecialty Non Steroidal Anti Inflammatory Drugs mastocytosis management adults immunometabolism ourdoor pollution allergic rhinitis Nomenclature EAACI Education training NSAIDs skin allergy Atopic dermatitis (AD) Anaphylaxis inflammaging tabacco smoke Drug allergy diagnosis task force healthcare barriers diagnostic tools skin diseases Pediatric children mmune senescence hypersensitivity drug provocation test diet therapy adverse events learning methods care pathways nasal allergen challenge Epidemiology Global air quality chronic spontaneous urticaria senolytic drugs position paper safety growth real-life settings primary care educational needs nasal provocation test Innovation World Health Organization (WHO) adolescent senomorphic drugs Proton pump inhibitor venom immunotherapy Nutrition risk factors primary care pediatricians immunotherapy guidelines allergic reactions integrated care
Authors
Agache, I. Riggioni, C. Meyer, R. Bavbek, S. Jesenak, M. Konstantinou, G Greenhawt, M. Brucker, H. Beken, B. Paoletti, G Rovati, G.E. Sigsgaard, T. Cardona, V. Leonardi, A. Kidon, M. Werfel, T Akdis, C.A. Inge Kortekaas Krohn Vandenplas, Y. Bonadonna, P. Simon, D. Mitsias, D. Venter, C Jeimy, S. Tsabouri, S. Hagemann, J. Benito Villalvilla, C. Ferastraoaru, D. Annesi-Maesano, I. Silva D. Rodrigues Cernadas J. Ardern-Jones, M.R. Sanna Toppila-Salmi Santos, A. Ferastraoaru DE Özdemir, S. K. Kappen, J. Konstantinou, G. Baerenfaller, K. de Blay, F. Alvarez-Perea, A. Onorato, G.L. Bergmann K.C. Romano A. Demoly, P. Gerth van Wijk, R. Augé J. Mockenhaupt, M. R. Fernandez-Santamaria Sietze Reitsma Bastl, M. Radzikowska, U. Arcolaci, A. Jutel, M. Bachert, C. Cornejo-Garcia, J.A. Aberer, W. Ricci, C. di Bona, D Buters J. Bastl K. Bonertz A. Nwaru B.I. Baumann, K.Y. de las Vecillas, L. Celik G.E Valérie Hox Berger, M Turner MC Feleszko, W. Zemelka-Wiacek, M. De Craemer, J. Bonini, M. Dörr, T. Wiehn, E. Paoletti, G. Karatzas K. Oussalah A Dreborg S. Golebski K. Vent J. Hilger, C. Mayorga, C Henry T. Bahnson Pfaar, O. Benito-Villalvilla C. Redel, A. L. Durban, R. Gevaert, P. Walsted, E.S. Zuberbier, T. Bernard, A. Eiwegger, T. Akkor, A. Yip V. Ebo, D.G. Kortekaas Krohn, I. Church, M.K. Hoffmann-Sommergruber, K. Hill, S.A. Hugh A. Sampson Bax, H.J. Roth-Walter, F. Barbaud, A. Reese, I. Buddingh E.P. Clark, E. Dunn Galvin, A. Couto, M. Ollert, M. Brockow, K. Bachmann M.F. Mertes P.M. Shikhagaie M.M. Clough, G.F. Mortz, C.G. Maria Ruabo-Zaragoza Stefania Arasi Bergmann, C. DunnGalvin, A. Garvey L.H. Skypala, I.J. Okarska-Napierała M. Flokstra – de Blok, B.M.J. Khaleva, E. Delgado, L. Sokolowska, M. Apfelbacher C. Bonini S. Bang B.E. Celik G.E. Gern, J. Hellings P. Nurmatov, U. Laura Carucci Pascal, M. Cabrera, M. Torres, M.J. Boni, E. Erlewyn-Lajeunesse, M. Poli, A. Knibb, R. Ambrożej, D. Böhm, I. Moscato G. Jensen-Jarolim E. Jeebhay, M. Whitaker P. Miller R. Antolin-Amerigo, D. Roberto Berni Canani Comotti, A. Levin, M. Çelik G.E. Sturm, G. Ryan, D. Garvey, L.H. Alvarez-Cuesta, E. Tramper-Stranders, G. Trautmann, A. Vultaggio, A. Venter, C. Bax H.J. Jha A. Beyer, K. Papadopoulos, N. Serena Coppola Douladiris, N. M. Erlewyn-Lajeunesse, D.R. Edelman, SM Bernstein, J. Alviani, C Palomares, O. Pagani, M. Atanaskovic-Markovic M. Baumann, R. Lukasik Z.M. Dramburg, S. Bianchini, R. Openshaw P. Fernandez-Rivas M. Price, O.J. Dimitrios Mitsias Vassilopoulou, E. Izquierdo, E. Nopp, A. Mosnaim G.S. Gore, C Rovati, G.E Angier, E. Blanca-Lopez, N. Zissler, U.M. Hoffmann, H.J. Matricardi, P. Alving K. Schwarze, J. Muraro, A. Arasi, S. George Konstantinou Abodi, M. Popescu, F. Adamiec, A. Anto, J. Vazquez-Ortiz, M. Sokolowska, M Janda, J. Gomes, E.R. Caubet, J.-C. Kalpaklioglu A.F Fleischer D.M. Vijverberg S. Blank S. Mueller, R.S. Brough, H.A. Julijana Asllani Alberti, I. Smolinska, S. Cieślik, M. Bousquet, J. Malinovschi, A. Cogo, A. Korath, A.D.J. Blain, H. Mori, F. Barber, D. Hox, V. Eguiluz-Gracia, I. Pali-Schöll I. Kowalski M.L Klimek, L. Chris Callewaert Milani, G.P. Álvaro-Lozano, M. Mączka, K. Shamji, M.H. Michel, M. Drijver-Messelink, M.T. Untersmayr, E. di Bona, D. Pfaller, B. Basinas, I. Jordens, A. Gayraud J. Verhoeckx K. Bilò, M.B. Adcock, I. Hafsa Belasri Lozinsky A.C. Rodríguez Del Río, P. Diamant, Z. Asllani, J. Vitte, J. Fieten, K.B. Feketea, G K Chu, D. Yepes-Nuñez, J.J. Doekes, G. Lourijsen, E. Formigo D.P. Gomes E. Fyhrquist, N
Year
2025 2024 2023 2022 2021 2020 2019 2018 2017 2014
Basophil Activation Test: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An EAACI Position Paper.
AllergoOncology: Microbiota in allergy and cancer – A European Academy for Allergy and Clinical Immunology position paper
Delayed hypersensitivity to antiepileptic drugs in children
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper
Endotypes in Immune Mediated Drug Reactions: Present and Future of Relevant Biomarkers. An EAACI Task Force Report
Otitis Media With Effusion (OME) and Eustachian Tube Dysfunction: The Role of Allergy and Immunity—An EAACI Position Paper
Exercise Recommendations and Practical Considerations for Asthma Management—An EAACI Position Paper
Systematic review of feeding difficulties in children with eosinophilic esophagitis: An EAACI Task Force report
Endotyping in Chronic Rhinosinusitis—An EAACI Task Force Report
Ultra-processed foods, allergy outcomes and underlying mechanisms in children: An EAACI task force report
Allergen immunotherapy adverse events in adults with respiratory allergies-data from ADER: An EAACI task force report
The influence of lifestyle and environmental factors on host resilience through a homeostatic skin microbiota: An EAACI Task Force Report
AAAAI–EAACI PRACTALL: Standardizing oral food challenges—2024 Update
The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper
EAACI Guidelines on the Management of IgE-Mediated Food Allergy
Comparison of two different pollen season definitions based on 10 years of birch and grass pollen data from two distant central European cities: An EAACI Task Force report
Granulocytes and mast cells in AllergoOncology—Bridging allergy to cancer: An EAACI position paper
EAACI guidelines on environmental science in allergic diseases and asthma
A systematic review and meta-analysis of nutritional and dietary interventions in randomized controlled trials for skin symptoms in children with atopic dermatitis and without food allergy: An EAACI task force report
A systematic review and meta-analysis on nutritional and dietary interventions for the treatment of acute respiratory infection in pediatric patients: An EAACI taskforce
Diagnosis and management of food allergy-induced constipation in young children—An EAACI position paper
AllergoOncology: Biomarkers and refined classification for research in the allergy and glioma nexus-A joint EAACI-EANO position paper
Digitally-enabled, person-centred care (PCC) in allergen immunotherapy: An ARIA-EAACI Position Paper
Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology
Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force
Global assessment of the knowledge and confidence in managing allergic disorders among primary care pediatricians across Europe: An EAACI task force report
Telemedicine with special focus on allergic diseases and asthma—Status 2022: An EAACI position paper
Feeding difficulties in children with food allergies: An EAACI Task Force Report
Hypersensitivity reactions to proton pump inhibitors. An EAACI position paper
A survey study on antibiotic prescription practices for acute asthma exacerbations: An European academy of allergy and clinical immunology task force report
A survey study on antibiotic prescription practices for acute asthma exacerbations: An European academy of allergy and clinical immunology task force report
A survey study on antibiotic prescription practices for acute asthma exacerbations: An European academy of allergy and clinical immunology task force report
EAACI/ENDA position paper on drug provocation testing
Flow-based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper
EAACI task force report: A consensus protocol for the basophil activation test for collaboration and external quality assurance
A systematic review and meta-analysis on absolute eosinophil counts and the risk of asthma in preschool children with wheezing: An EAACI Task Force Report
Eosinophils – from cradle to grave: An EAACI task force paper on new molecular insights and clinical functions of eosinophils and the clinical effects of targeted eosinophil depletion
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper
EAACI guidelines on the diagnosis of IgE-mediated food allergy
Food allergy – A holistic approach to dietary management. A joint EAACI Research & Outreach Committee and INDANA review
Allergy to stings and bites from rare or locally important arthropods: Worldwide distribution, available diagnostics and treatment
The One Health approach for allergic diseases and asthma
Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies – Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology task force
The Allergen Immunotherapy Adverse Events Registry: Setup & methodology of a European Academy of Allergy and Clinical Immunology taskforce project
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis
Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paper
Preliminary pilot study results of the EAACI allergy educational needs in primary care pediatricians Task Force in managing allergic disorders
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paper
Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergy
Health effects of exposure to chlorination by – products in swimming pools
Role of dietary fiber in promoting immune health – An EAACI position paper
Diagnosis and management of allergy and respiratory disorders in sport: An EAACI task force position paper
Omics technologies in allergy and asthma research: An EAACI position paper
Diagnosis and management of food allergy-associated gastroesophageal reflux disease in young children – EAACI position paper
Allergic and hypersensitivity conditions in non-specialist care: Flow diagrams to support clinical practice
AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper
Allergies and COVID-19 vaccines: An ENDA/ EAACI Position paper
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendations
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19
Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position Paper
Cannabis-related allergies: an international overview and consensus recommendations
World Health Organization global air quality guideline recommendations: Executive summary
The international WAO/ EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research priorities
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper
EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update)
Perceptions of adolescents and young adults with allergy and/ or asthma and their parents on EAACI guideline recommendations about transitional care: A European survey
EAACI Biologicals Guidelines – dupilumab for children and adults with moderate-to-severe atopic dermatitis
The international EAACI/ GA²LEN/ EuroGuiDerm/ APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Current allergy educational needs in primary care. Results of the EAACI working group on primary care survey exploring the confidence to manage and the opportunity to refer patients with allergy
Hypersensitivity reactions to chemotherapy: an EAACI position paper
EAACI guidelines: Anaphylaxis (2021 update)
Hypersensitivity reactions to biological agents: An EAACI position paper
One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-CoV-2
A multi-disciplinary approach to the diagnosis and management of allergic disease: An EAACI Task Force
A European survey of management approaches in chronic urticaria in children: EAACI Paediatric Urticaria Taskforce
EAACI Biologicals Guidelines – Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years old
Adherence to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist in articles published in EAACI Journals: A bibliographic study
Technical standards in allergen exposure chambers worldwide – an EAACI Task Force Report
Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseases
An EAACI Task Force report on allergy to beta-lactams in children: Clinical entities and diagnostic procedures
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Allergen immunotherapy: The growing role of observational and randomized trial “Real-World Evidence”
EAACI Biologicals Guidelines – Treatment with biologicals for severe chronic rhinosinusitis with nasal polyps
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA Position Paper
EAACI Biologicals Guidelines – Recommendations for severe asthma
Allergen immunotherapy for respiratory allergy: quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool
Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity
Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseases
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper
Placebo effects in allergen immunotherapy – An EAACI Task Force Position Paper
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ ARIA Position Paper
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)
EAACI Biologicals Guidelines – dupilumab for children and adults with moderate-to-severe atopic dermatitis
Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the task force on immunopharmacology (TIPCO)
Biologicals in atopic disease in pregnancy: An EAACI position paper
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I
The development of birch pollen seasons over 30 years in Munich, Germany – An EAACI task force report
Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19: An EAACI position paper
Gender and occupational allergy: Report from the task force of the EAACI Environmental and Occupational Allergy Interest Group
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement
EAACI Guidelines on the effective transition of adolescents and young adults with allergy and asthma
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives – A report of the European Academy of Allergy and Clinical Immunology (EAACI)
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan – An EAACI position paper
EAACI Research and Outreach Committee: Improving standards and facilitating global collaboration through a Research Excellence Network
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement
Respiratory diseases and allergy in farmers working with livestock: a EAACI position paper
AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer – a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)
Towards a more precise diagnosis of hypersensitivity to beta-lactams – an EAACI position paper
Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas – An EAACI Task Force Report
Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review – An EAACI position paper
State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)
EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthma
The role of mobile health technologies in allergy care: An EAACI position paper
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants – An EAACI Position Paper
Prioritizing research challenges and funding for allergy and asthma and the need for translational research – The European Strategic Forum on Allergic Diseases
An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions
Food processing and occupational respiratory allergy- An EAACI position paper
Toward clinically applicable biomarkers for asthma: An EAACI position paper
Management of ocular allergy
EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitis
A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergy
Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paper
EAACI position paper: Comparing insect hypersensitivity induced by bite, sting, inhalation or ingestion in human beings and animals
EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma
Skin microdialysis: methods, applications and future opportunities – an EAACI position paper
Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall document
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD) – a EAACI position paper
The roadmap for the Allergology specialty and allergy care in Europe and adjacent countries. An EAACI position paper
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity
Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needs
The urgent need for a harmonized severity scoring system for acute allergic reactions
EAACI Position paper on the standardization of nasal allergen challenges
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents
Influenza burden, prevention, and treatment in asthma – A scoping review by the EAACI Influenza in asthma task force
EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy
EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis
Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy
The roadmap for allergology in Europe: The subspecialty of allergology as “stop-over” on the way to a full specialty. An EAACI position statement
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer
Current practice of allergy diagnosis and the potential impact of regulation in Europe
EAACI guidelines on allergen immunotherapy: Prevention of allergy
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
Show more GUIDELINES & POSITIONS PAPERS
